We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+19.61%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.63B
AUM Growth
+$411M
Cap. Flow
+$161M
Cap. Flow %
6.13%
Top 10 Hldgs %
44.92%
Holding
2,471
New
804
Increased
452
Reduced
440
Closed
595

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$13.4M
2
BOLD
Audentes Therapeutics, Inc
BOLD
+$10.5M
3
CISN
Cision Ltd. Ordinary Share
CISN
+$10M
4
MDCO
Medicines Co
MDCO
+$8.78M
5
TIF
Tiffany & Co.
TIF
+$7.91M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$42.5M
2
VSM
Versum Materials, Inc.
VSM
+$29.7M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$23.3M
4
AABA
Altaba Inc
AABA
+$18.8M
5
CPE
Callon Petroleum Company
CPE
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 4.59%
2 Healthcare 3.78%
3 Consumer Discretionary 3.06%
4 Communication Services 2.48%
5 Real Estate 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECOM
1176
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$81K ﹤0.01%
8,908
+1,200
+16% +$11K
JCAP
1177
DELISTED
Jernigan Capital, Inc.
JCAP
$81K ﹤0.01%
+4,214
New +$77.5K
USX
1178
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$80K ﹤0.01%
16,000
+8,000
+100% +$39K
GCP
1179
DELISTED
GCP Applied Technologies Inc.
GCP
$80K ﹤0.01%
3,538
-62
-2% -$1.33K
UNM icon
1180
Unum
UNM
$14.3B
$79K ﹤0.01%
2,722
+1,616
+146% +$47K
AUPH icon
1181
PUT
Aurinia Pharmaceuticals
AUPH
$2.11B
$77K ﹤0.01%
+3,800
New +$35K
FNB icon
1182
FNB Corp
FNB
$6.75B
$77K ﹤0.01%
+6,049
New +$74.2K
NTRS icon
1183
Northern Trust
NTRS
$33.9B
$77K ﹤0.01%
+729
New +$74.6K
SCO icon
1184
CALL
ProShares UltraShort Bloomberg Crude Oil
SCO
$671M
$77K ﹤0.01%
+75
New +$87.2K
SMPL icon
1185
Simply Good Foods
SMPL
$982M
$77K ﹤0.01%
2,685
-4,221
-61% -$111K
PDCE
1186
DELISTED
PDC Energy, Inc.
PDCE
$77K ﹤0.01%
2,931
+1,980
+208% +$47.5K
XRN
1187
Chiron Real Estate Inc
XRN
$477M
$76K ﹤0.01%
+1,156
New +$72.6K
HCA icon
1188
HCA Healthcare
HCA
$89.5B
$76K ﹤0.01%
517
-1,858
-78% -$250K
WST icon
1189
West Pharmaceutical
WST
$24.9B
$76K ﹤0.01%
507
+485
+2,205% +$70.6K
ROSE
1190
DELISTED
Rosehill Resources Inc. Class A
ROSE
$76K ﹤0.01%
59,145
– –
ADM icon
1191
Archer Daniels Midland
ADM
$36.9B
$75K ﹤0.01%
+1,624
New +$69.3K
ECL icon
1192
Ecolab
ECL
$79.9B
$75K ﹤0.01%
391
-1,469
-79% -$279K
GIS icon
1193
PUT
General Mills
GIS
$19.7B
$75K ﹤0.01%
+1,400
New +$73.8K
TT icon
1194
Trane Technologies
TT
$106B
$75K ﹤0.01%
567
+489
+627% +$62K
VRSK icon
1195
Verisk Analytics
VRSK
$25B
$75K ﹤0.01%
500
+274
+121% +$40.6K
WSO icon
1196
Watsco Inc
WSO
$13.6B
$75K ﹤0.01%
+416
New +$73.2K
XLY icon
1197
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$75K ﹤0.01%
+1,200
New +$73K
PACW
1198
DELISTED
PacWest Bancorp
PACW
$75K ﹤0.01%
1,947
+1,102
+130% +$41.4K
WAAS
1199
DELISTED
AquaVenture Holdings Limited
WAAS
$75K ﹤0.01%
+2,767
New +$58.7K
DPLO
1200
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$75K ﹤0.01%
+18,810
New +$88.4K
46 47
48
49 50

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Prelude Capital Management held 2,471 positions worth $2.63B, up 19% from $2.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prelude Capital Management deployed $161M of net new capital in Q4 2019, opening 804 new positions and adding to 452 existing holdings. Its largest new stake was Netflix: 452,870 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Callon Petroleum Company, an estimated $17.2M trimmed.

  • Prelude Capital Management's largest Q4 2019 buy was Netflix: 452,870 shares worth $14.7M.
  • Prelude Capital Management added most to Cision Ltd. Ordinary Share in Q4 2019, an estimated $10M increase.
  • Prelude Capital Management's biggest Q4 2019 reduction was Callon Petroleum Company, cutting an estimated $17.2M.
  • Prelude Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $42.5M.
  • Prelude Capital Management's ten largest holdings make up 45% of its $2.63B portfolio in Q4 2019.
  • Prelude Capital Management opened 804 new positions and closed 595 in Q4 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $2.63B.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.